compounded semaglutide crackdown news november 2025 Drug compounders sue FDA over declaration ending Wegovy shortage The FDA has received reports

Reply The Medicare.gov Bridge Program website, under Eligibility, indicates 30 bmi+ with prediabetes is eligible

Theres an opportunity for diet brands to develop new products or adapt their existing offering with innovations that can meet both the nutritional needs, the metabolic needs, and even the aesthetical new needs [of GLP-1 drug users.] For example, GLP-1 drug users can lose significant muscle mass, with some studies suggesting muscle loss can account for between 25-39% of total weight lost, versus 10-30% via traditional weight loss methods, driving demand for high-protein pre-portioned meal solutions

Ask your pharmacist or health care provider to explain or demonstrate

Part IV